Study to Evaluate the Immunogenicity, Reatogenicity and Safety of Double Viral Vaccine (MR) for Measles and Rubella

NCT03148990 · clinicaltrials.gov ↗
PHASE2,PHASE3
Phase
COMPLETED
Status
432
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

The Immunobiological Technology Institute (Bio-Manguinhos) / Oswaldo Cruz Foundation (Fiocruz)

Collaborators